Additionally, intranasal delivery of active CatG in mice induces inflammation by recruiting immune cells to the lung tissue and degradation of PLTP (Figure 2A); a blockade of PLTP destruction inhibits lung inflammation in COPD (Brehm et al., 2014). Here, PLTP is linked to chronic obstructive pulmonary disease.